201 related articles for article (PubMed ID: 7803980)
1. Etiological review of hirsutism in 250 patients.
Morán C; Tapia MC; Hernández E; Vázquez G; García-Hernández E; Bermúdez JA
Arch Med Res; 1994; 25(3):311-4. PubMed ID: 7803980
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of late-onset adrenal 3 beta-ol-hydroxysteroid dehydrogenase deficiency in patients with hirsutism and polycystic ovaries.
Morán C; Tena G; Herrera J; Bermúdez JA; Zárate A
Arch Med Res; 1994; 25(3):315-20. PubMed ID: 7803981
[TBL] [Abstract][Full Text] [Related]
3. The clinical evaluation of hirsutism.
Somani N; Harrison S; Bergfeld WF
Dermatol Ther; 2008; 21(5):376-91. PubMed ID: 18844715
[TBL] [Abstract][Full Text] [Related]
4. Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment.
Luboshitzky R; Herer P; Shen-Orr Z
Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):102-7. PubMed ID: 15031776
[TBL] [Abstract][Full Text] [Related]
5. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
6. [Hirsutism].
van Zuuren EJ; Pijl H
Ned Tijdschr Geneeskd; 2007 Oct; 151(42):2313-8. PubMed ID: 18064932
[TBL] [Abstract][Full Text] [Related]
7. A detailed investigation of hirsutism in a Turkish population: idiopathic hyperandrogenemia as a perplexing issue.
Unluhizarci K; Gokce C; Atmaca H; Bayram F; Kelestimur F
Exp Clin Endocrinol Diabetes; 2004 Oct; 112(9):504-9. PubMed ID: 15505757
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
Meczekalski B; Slopien R; Warenik-Szymankiewicz A
Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of polycystic ovary syndrome in women with mild hirsutism and no other significant clinical symptoms.
Di Fede G; Mansueto P; Pepe I; Rini GB; Carmina E
Fertil Steril; 2010 Jun; 94(1):194-7. PubMed ID: 19338993
[TBL] [Abstract][Full Text] [Related]
10. Approach to patients with hirsutism.
Sakiyama R
West J Med; 1996 Dec; 165(6):386-91. PubMed ID: 9000866
[TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance.
Lemay A; Dodin S; Turcot L; Déchêne F; Forest JC
Hum Reprod; 2006 Jan; 21(1):121-8. PubMed ID: 16199428
[TBL] [Abstract][Full Text] [Related]
12. [Androgenization in patients with polycystic ovary syndrome].
Gasparov AS; Pshenichnikova TIa; Alieva EA; Fedorova TA; Vetr M
Acta Univ Palacki Olomuc Fac Med; 1990; 126():241-6. PubMed ID: 2151091
[TBL] [Abstract][Full Text] [Related]
13. Clinical presentation and etiologic factors of hirsutism in premenopausal Iranian women.
Ansarin H; Aziz-Jalali MH; Rasi A; Soltani-Arabshahi R
Arch Iran Med; 2007 Jan; 10(1):7-13. PubMed ID: 17198446
[TBL] [Abstract][Full Text] [Related]
14. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
15. Cyproterone acetate treatment of females with hyperandrogenism.
Julesz J; Faredin I; Tóth I; László FA
Endokrinologie; 1981 Dec; 78(2-3):168-74. PubMed ID: 6460612
[TBL] [Abstract][Full Text] [Related]
16. [Obesity, arterial hypertension, metabolic disorders, and polycystic ovary syndrome].
Quiñónez Zarza C; Silva Ruiz R; Torres Juárez JM
Ginecol Obstet Mex; 2000 Jul; 68():317-22. PubMed ID: 11006648
[TBL] [Abstract][Full Text] [Related]
17. Spironolactone for hirsutism in polycystic ovary syndrome.
Christy NA; Franks AS; Cross LB
Ann Pharmacother; 2005 Sep; 39(9):1517-21. PubMed ID: 16076921
[TBL] [Abstract][Full Text] [Related]
18. [Current opinions on the etiology and pathophysiology of hirsutism].
Krysiak R; Kedzia A; Okopień B
Pol Merkur Lekarski; 2012 May; 32(191):335-40. PubMed ID: 22779343
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism.
Batukan C; Muderris II
Fertil Steril; 2006 Feb; 85(2):436-40. PubMed ID: 16595223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
